112 related articles for article (PubMed ID: 18047790)
1. Induction of megakaryocytic differentiation in chronic myelogenous leukemia cell K562 by 3-hydrogenkwadaphnin.
Meshkini A; Yazdanparast R
J Biochem Mol Biol; 2007 Nov; 40(6):944-51. PubMed ID: 18047790
[TBL] [Abstract][Full Text] [Related]
2. 3-Hydrogenkwadaphnine, a novel diterpene ester from Dendrostellera lessertii, its role in differentiation and apoptosis of KG1 cells.
Yazdanparast R; Meshkini A
Phytomedicine; 2009 Mar; 16(2-3):206-14. PubMed ID: 18829278
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ERK/MAPK pathway in megakaryocytic differentiation of K562 cells induced by 3-hydrogenkwadaphnin.
Meshkini A; Yazdanparast R
Toxicol In Vitro; 2008 Sep; 22(6):1503-10. PubMed ID: 18586450
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydrogenkwadaphnin induces monocytic differentiation and enhances retinoic acid-mediated granulocytic differentiation in NB4 cell line.
Moosavi MA; Yazdanparast R; Lotfi A
J Biochem Mol Biol; 2006 Nov; 39(6):722-9. PubMed ID: 17129408
[TBL] [Abstract][Full Text] [Related]
5. 3-Hydrogenkwadaphnin targets inosine 5'-monophosphate dehydrogenase and triggers post-G1 arrest apoptosis in human leukemia cell lines.
Moosavi MA; Yazdanparast R; Sanati MH; Nejad AS
Int J Biochem Cell Biol; 2005 Nov; 37(11):2366-79. PubMed ID: 16084123
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxic and anti-proliferative effects of 3-hydrogenkwadaphnin in K562 and jurkat cells is reduced by guanosine.
Moosavi MA; Yazdanparast R; Sanati MH
J Biochem Mol Biol; 2005 Jul; 38(4):391-8. PubMed ID: 16053705
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.
Yen JH; Lin CY; Chuang CH; Chin HK; Wu MJ; Chen PY
Cells; 2020 Apr; 9(4):. PubMed ID: 32260160
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydrogenkwadaphnin from Dendrostellera lessertii induces differentiation and apoptosis in HL-60 cells.
Yazdanparast R; Moosavi MA; Mahdavi M; Sanati MH
Planta Med; 2005 Dec; 71(12):1112-7. PubMed ID: 16395646
[TBL] [Abstract][Full Text] [Related]
9. Guanosine supplementation reduces the antiproliferative and apoptotic effects of the IMPDH inhibitor gnidilatimonoein in K562 cells.
Nouri K; Yazdanparast R; Sarafnejad A
Cell Biol Int; 2011 Oct; 35(10):1001-8. PubMed ID: 21476989
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and apoptosis of U-937 leukemia cells by an active compound from Dendrostellera lessertii.
Meshkini A; Yazdanparast R; Haidari M
Iran Biomed J; 2009 Jan; 13(1):35-42. PubMed ID: 19252676
[TBL] [Abstract][Full Text] [Related]
11. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
12. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
13. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
14. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells.
Lou YJ; Jin J
Leuk Lymphoma; 2004 Feb; 45(2):373-6. PubMed ID: 15101726
[TBL] [Abstract][Full Text] [Related]
15. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.
Colosetti P; Puissant A; Robert G; Luciano F; Jacquel A; Gounon P; Cassuto JP; Auberger P
Autophagy; 2009 Nov; 5(8):1092-8. PubMed ID: 19786835
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
17. CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B; Martín-Rodríguez P; Díaz-Chico JC; McNaughton-Smith G; Jiménez-Alonso S; Hueso-Falcón I; Montero JC; Blanco R; León J; Rodríguez-González G; Estévez-Braun A; Pandiella A; Díaz-Chico BN; Fernández-Pérez L
Oncotarget; 2017 May; 8(18):29679-29698. PubMed ID: 27557509
[TBL] [Abstract][Full Text] [Related]
18. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
19. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.
Jacquel A; Herrant M; Legros L; Belhacene N; Luciano F; Pages G; Hofman P; Auberger P
FASEB J; 2003 Nov; 17(14):2160-2. PubMed ID: 14597677
[No Abstract] [Full Text] [Related]
20. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
Hekmatshoar Y; Ozkan T; Altinok Gunes B; Bozkurt S; Karadag A; Karabay AZ; Sunguroglu A
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):23-30. PubMed ID: 29808796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
